aTyr Pharma ATYR Return on invested capital

Return on invested capital at other companies

Bristol-Myers SquibbBMY

16.7%+8.4pp

Merck & Co.MRK

3.7%-18.0pp

Design Therapeutics, Inc.DSGN

-37.1%+12.1pp

Oric Pharmaceuticals, Inc.ORIC

-55.9%-7.1pp

Syndax PharmaceuticalsSNDX

-67.9%-12.9pp

Stoke Therapeutics, Inc.STOK

-114.4%—

FAQ

What is aTyr Pharma's return on invested capital?

aTyr Pharma (ATYR) reported return on invested capital of -110.8% in Q2 2026.

How has aTyr Pharma's return on invested capital changed year-over-year?

aTyr Pharma's return on invested capital decreased by 26.5% year-over-year, from -87.5% to -110.8%.

What is the long-term trend for aTyr Pharma's return on invested capital?

Over 5 years (2020 to 2025), aTyr Pharma's return on invested capital has grown at a 6.9% compound annual growth rate (CAGR), from -78.3% to -109.2%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.